Combined antiretroviral and antituberculosis drug resistance following incarceration

Autor: Stott, KE, de Oliviera, T, Lessells, RJ

Publikováno v: Southern African Journal of HIV Medicine; Vol 14, No 3 (2013); 135-137

We describe a case of HIV/tuberculosis (TB) co-infection from KwaZulu-Natal, South Africa, characterised by drug resistance in both pathogens. The development of drug resistance was linked temporally to two periods of incarceration. This highlights t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=78975075580c::ad7b0732a9556e7e604735563769c8a2
https://www.ajol.info/index.php/sajhivm/article/view/94801

Assessing Arctica islandica as a proxy for Scottish marine climate change

Autor: Stott, Keziah Jane

This thesis investigates the potential of the bivalve Arctica islandica (Linnaeus, 1767) from fjordic sites in NW Scotland for reconstructing past marine environmental /climatic variability. Using dendrochronological and sclerochronological technique

Externí odkaz: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.605815

The role of glutamine repeats in proteins

Autor: Stott, Kelvin Robert

Externí odkaz: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.621642

Integration of genomic and pharmacokinetic data to predict clinical outcomes in HIV-associated cryptococcal meningitis.

Autor: Stott KE; Antimicrobial Pharmacodynamics and Therapeutics Group, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom.; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Mohabir JT; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Bowers K; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Tenor JL; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Toffaletti DL; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Unsworth J; Antimicrobial Pharmacodynamics and Therapeutics Group, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Jimenez-Valverde A; Antimicrobial Pharmacodynamics and Therapeutics Group, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Ahmadu A; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Moyo M; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi.; Department of Medicine, Kamuzu University of Health Sciences, Blantyre, Malawi., Gondwe E; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Chimang'anga W; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Chasweka M; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Lawrence DS; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Tropical Medicine, London, United Kingdom.; Botswana Harvard Health Partnership, Gaborone, Botswana.; Clinical Microbiology and Infectious Diseases, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Jarvis JN; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Tropical Medicine, London, United Kingdom.; Botswana Harvard Health Partnership, Gaborone, Botswana., Harrison T; Institute of Infection and Immunity, St George's University London, London, United Kingdom., Hope W; Antimicrobial Pharmacodynamics and Therapeutics Group, Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, United Kingdom., Lalloo DG; Liverpool School of Tropical Medicine, Liverpool, United Kingdom., Mwandumba HC; Malawi Liverpool Wellcome Clinical Research Programme, Blantyre, Malawi., Perfect JR; Division of Infectious Diseases, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Cuomo CA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

Publikováno v: MBio [mBio] 2024 Oct 16; Vol. 15 (10), pp. e0159224. Date of Electronic Publication: 2024 Aug 27.

Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis.

Autor: Giamberardino CD; Department of Medicine, Division of Infectious Diseases, Duke University , Durham, North Carolina, USA., Tenor JL; Department of Medicine, Division of Infectious Diseases, Duke University , Durham, North Carolina, USA., Toffaletti DL; Department of Medicine, Division of Infectious Diseases, Duke University , Durham, North Carolina, USA., Palmucci JR; Department of Medicine, Division of Infectious Diseases, Duke University , Durham, North Carolina, USA., Schell W; Department of Medicine, Division of Infectious Diseases, Duke University , Durham, North Carolina, USA., Boua J-VK; Department of Neurosurgery, Duke University , Durham, North Carolina, USA., Marius C; Department of Neurosurgery, Duke University , Durham, North Carolina, USA., Stott KE; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, University of Liverpool , Liverpool, United Kingdom., Steele SL; Appili Therapeutics Inc. , Halifax, Nova Scotia, Canada., Hope W; Antimicrobial Pharmacodynamics and Therapeutics, Department of Molecular and Clinical Pharmacology, University of Liverpool , Liverpool, United Kingdom., Cilla D; Appili Therapeutics Inc. , Halifax, Nova Scotia, Canada., Perfect JR; Department of Medicine, Division of Infectious Diseases, Duke University , Durham, North Carolina, USA.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2023 Oct 18; Vol. 67 (10), pp. e0081823. Date of Electronic Publication: 2023 Sep 20.